These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17227228)

  • 1. NF-kappa B as a therapeutic target in autoimmune disease.
    O'Sullivan B; Thompson A; Thomas R
    Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.
    Herrington FD; Carmody RJ; Goodyear CS
    J Biomol Screen; 2016 Mar; 21(3):223-42. PubMed ID: 26597958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.
    Miraghazadeh B; Cook MC
    Front Immunol; 2018; 9():613. PubMed ID: 29686669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis.
    Valaperti A
    Curr Pharm Des; 2016; 22(4):440-9. PubMed ID: 26696258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B as a therapeutic target in neurodegenerative diseases.
    Camandola S; Mattson MP
    Expert Opin Ther Targets; 2007 Feb; 11(2):123-32. PubMed ID: 17227229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B as a target for cancer therapy.
    Melisi D; Chiao PJ
    Expert Opin Ther Targets; 2007 Feb; 11(2):133-44. PubMed ID: 17227230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappaB pathway as a potential target for autoimmune disease therapy.
    Bacher S; Schmitz ML
    Curr Pharm Des; 2004; 10(23):2827-37. PubMed ID: 15379671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
    Saito K; Mori S; Date F; Hong G
    Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of NF-kappa B in virus-infected macrophages is dependent on mitochondrial oxidative stress and intracellular calcium: downstream involvement of the kinases TGF-beta-activated kinase 1, mitogen-activated kinase/extracellular signal-regulated kinase kinase 1, and I kappa B kinase.
    Mogensen TH; Melchjorsen J; Höllsberg P; Paludan SR
    J Immunol; 2003 Jun; 170(12):6224-33. PubMed ID: 12794154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of nuclear factor-κB in autoimmunity.
    Sun SC; Chang JH; Jin J
    Trends Immunol; 2013 Jun; 34(6):282-9. PubMed ID: 23434408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
    Lopez-Guerra M; Colomer D
    Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting NF-kappaB for colorectal cancer.
    Sakamoto K; Maeda S
    Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.
    Ouk S; Liou ML; Liou HC
    Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear IκBs in inflammation regulation.
    Chiba T; Inoko H; Kimura M; Sato T
    Biomol Concepts; 2013 Apr; 4(2):187-96. PubMed ID: 25436575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis.
    Yan J; Greer JM
    CNS Neurol Disord Drug Targets; 2008 Dec; 7(6):536-57. PubMed ID: 19128210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
    Freitas RHCN; Fraga CAM
    Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
    Collister KA; Albensi BC
    Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Rel/NF-kappa-B transcription factors: complex role in cell regulation].
    Bottex-Gauthier C; Pollet S; Favier A; Vidal DR
    Pathol Biol (Paris); 2002 Apr; 50(3):204-11. PubMed ID: 11980335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.